Renovatio Clinical

El Paso, Texas 79915

1 studies enrolling now · 9 studies all time

What they study most

1st Line NSCLC, Advanced Cancer, Advanced Non-Small Cell Lung Cancer, Advanced Solid Tumor, CLL/SLL, Cancer, Carcinoma, Non-Small-Cell Lung, Colorectal Cancer, DLBCL, Follicular Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lung Cancer (NSCLC)

Studies at this site

• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers — Recruiting now
• A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer — Recruiting now
• A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs — Recruiting now
• A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia — Running, not enrolling
• A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) — Running, not enrolling
• Study of INKmune in Patients With mCRPC (CaRe Prostate) — Completed
• Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC — Running, not enrolling
• HMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHL — Withdrawn before enrolling